Higher immune cell counts in AIDS patients treated with highly active antiretroviral therapy (HAART) are associated a lower incidence of Kaposi sarcoma and non-Hodgkin lymphoma.
3 people have died in Tibet from AIDS and the number of reported HIV carriers and people with full-blown AIDS has risen to 41 compared to 30 cases last year.
Rare, previously undetectable drug-resistant forms of HIV have been identified by Yale School of Medicine researcher Michael Kozal, M.D., using an innovative genome sequencing technology that quickly detects rare viral mutations.
In a finding that could have important implications for HIV vaccine research, new research at Weill Cornell Medical College illuminates the ways in which the body prevents its mucosal surfaces from being overwhelmed by bacteria.
A targeted campaign of testing and counseling aimed at those who are at high risk for HIV would be more effective than the mass patient screening proposed by the Centers for Disease Control and Prevention (CDC), according to an analysis by David Holtgrave, PhD, an expert on HIV prevention at the Johns Hopkins Bloomberg School of Public Health.
Roger Pebody from Terrence Higgins Trust said: It?s essential that anyone taking Nelfinavir (Viracept) contacts their HIV doctor or hospital without delay, to identify an alternative treatment to continue with.
As top officials from the Group of Eight (G8) industrialized countries gather in Germany for their summit meeting today, the main United Nations agency dealing with AIDS urged them to show continued leadership on the issue.
AIDS Healthcare Foundation (AHF), the US? largest provider of HIV/AIDS healthcare, education and prevention and operator of free AIDS treatment clinics in the US, Africa, Latin America/Caribbean and Asia, today praised Merck for its decision to offer to reduce the price of its antiretroviral drug, efavirenz (marketed outside the US under the brand name Strocrin), in Thailand, but chided the multinational drug company for making the price cut offer contingent upon the Government of Thailand revoking a compulsory license it had issued in November 2006 for the manufacture and/or importation of a generic version of the drug.
Roche, in agreement and cooperation with Health Authorities (EMEA and Swissmedic), recalls in Europe and some other world regions all batches of Viracept powder and tablets. The US, Canada and Japan are not affected by this recall.
The World Health Organization (WHO) today warmly welcomed the United States’ proposal to commit a further $30 billion to the President’s Emergency Plan for AIDS Relief and extend the Plan for another five years.